Cargando...
Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol
Objective: To investigate the course of CBG during anti-TNF treatment in RA. Methods: 13 patients with longstanding RA, without prior prednisolone treatment, were included in this longitudinal study with subcutaneous adalimumab. Results: Treatment with anti-TNF markedly decreased clinical markers of...
Gardado en:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2005
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1755630/ https://ncbi.nlm.nih.gov/pubmed/15708882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2004.031997 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|